Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 3276
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT00074750 | Study of DT388GMCSF Fusion Protein in Acute Myelogenous Leukemia (AML) and Chronic Myelomonocytic Leukemia (CMML) | ||
| NCT02420691 | Ribociclib in Treating Patients With Advanced Neuroendocrine Tumors of Foregut Origin | ||
| NCT01816659 | An Open-Labeled Pilot Study of Biomarker Response Following Short-Term Exposure to Metformin | ||
| NCT03964896 | Nurse-Driven Telephone Intervention in Improving Side Effects in Cancer Patients Undergoing Chemotherapy | ||
| NCT01603303 | Preventing Sexual Dysfunction With Aromatase Inhibitors | ||
| NCT01253460 | Sapacitabine, Cyclophosphamide, Rituximab for Relapsed Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma (CLL/SLL) With Deletion (11q22-23) | ||
| NCT05733091 | Assessment of Functional and Symptom Outcomes for Survivors of Paranasal Sinus, Nasopharyngeal and Skull Base Tumors | ||
| NCT00490503 | Non-Invasive Magnetic Resonance Imaging (MRI) and Magnetic Resonance Spectroscopy Techniques (MRS) for Assessing Neoadjuvant Chemotherapy in Locally Advanced Breast Cancer | ||
| NCT04435691 | Magrolimab, Azacitidine, and Venetoclax for the Treatment of Acute Myeloid Leukemia | ||
| NCT01424982 | Combination Chemotherapy and Ponatinib Hydrochloride in Treating Patients With Acute Lymphoblastic Leukemia | ||
| NCT06285890 | Phase I Study of HC-7366 for Acute Myeloid Leukemia | ||
| NCT02726997 | Matched Paired Pharmacodynamics and Feasibility Study of Durvalumab in Combination With Chemotherapy in Frontline Ovarian Cancer (N-Dur) | ||
| NCT05120960 | A Phase 1a/1b Study to Determine the Recommended Phase 2 Dose, of Tepotinib in Participants With MET Alterations and Brain Tumors | ||
| NCT01204788 | Prophylactic White Cell Transfusions Versus Therapeutic White Cell Transfusions in Patients With Leukemia | ||
| NCT04216524 | Venetoclax, SL-401, and Chemotherapy for the Treatment of Blastic Plasmacytoid Dendritic Cell Neoplasm | ||
| NCT00518388 | Perceptions of Cervical Cancer Among Asian Americans | ||
| NCT04835597 | Precision Performance Status Assessment in Breast Cancer Patients Receiving Neoadjuvant Chemotherapy | ||
| NCT04560673 | Duloxetine and Neurofeedback Training for the Treatment of Chemotherapy Induced Peripheral Neuropathy | ||
| NCT06199466 | A Trial of YL-13027 in Combination With Gemcitabine and Nab-paclitaxel in Patients With Refractory Metastatic Pancreatic Cancer | ||
| NCT01562301 | Sublingual Anvirzel in Advance Non-Small Cell Lung Cancer (NSCLC) | ||
| NCT07140965 | The Impact of Surgeon-Interpreted Intraoperative Margin Assessment During Breast Conserving Surgery on Postoperative Treatment | ||
| NCT03138967 | Investigation of Sugammadex in Outpatient Urological Procedures | ||
| NCT02389751 | Ganetespib in Combination With Paclitaxel, Carboplatin, and Radiation Therapy in Treating Patients With Stage II-III Esophageal Cancer | ||
| NCT02159872 | Omacetaxine in Patients With Intermediate-1 and Higher Risk Myelodysplastic Syndrome (MDS) Post Hypomethylating Agent (HMA) Failure | ||
| NCT03295227 | Pembrolizumab in Treating Participants With Unresectable Thymoma or Thymic Cancer | ||
| NCT04185337 | Ultrasound-Guided Photoacoustic Imaging for the Detection of Metastases in Inguinal Lymph Nodes | ||
| NCT05041153 | Pembrolizumab and Lenvatinib for the Treatment of Advanced, Unresectable, or Metastatic Gastroesophageal Adenocarcinoma | ||
| NCT03108131 | Cobimetinib and Atezolizumab in Treating Participants With Advanced or Refractory Rare Tumors | ||
| NCT02321501 | Ceritinib and Everolimus in Treating Patients With Locally Advanced or Metastatic Solid Tumors or Stage IIIB-IV Non-small Cell Lung Cancer | ||
| NCT01339871 | Study of Pazopanib and Vorinostat in Patients With Advanced Malignancies | ||
| NCT05012371 | Lenvatinib With Everolimus Versus Cabozantinib for Second-Line or Third-Line Treatment of Metastatic Renal Cell Cancer | ||
| NCT00506129 | Allogeneic Transplantation in Patients With Cutaneous T-Cell Lymphoma | ||
| NCT00972101 | Infusion of Expanded Cord Blood T Cells | ||
| NCT01169753 | Nuvigil in Treatment of Cancer-Related Fatigue in Chronic Myeloid Leukemia Patients | ||
| NCT00822965 | Enhancing Knowledge Implantable Cardioverter-Defibrillators (ICDs) | ||
| NCT00038623 | Study Of Yttrium-ibritumomab (Zevalin) For the Treatment Of Patients With Relapsed And Refractory Mantle Cell Lymphoma | ||
| NCT06584396 | Evaluating Mechanical Properties of Post-Mastectomy Skin Flaps to Estimate Reconstruction Risks, the EMPOWER Study | ||
| NCT05034562 | Gallium-68 PSMA-11 PET in Participants With Prostate Cancer | ||
| NCT06815354 | Comprehensive Assessment of Cancer Theranostic Response | ||
| NCT00510653 | Gleevec Study for Patients With Ovarian Cancer | ||
| NCT04889937 | Usability, Adherence and Diagnostic Performance of PointCheck in Pediatric Population | ||
| NCT05496972 | Survey Assessment of Patient and Provider Impressions of Telemedicine in Radiation Oncology | ||
| NCT02255773 | Exploring the Neuro-Immune Basis of Cancer-Related Fatigue Using Behavioral Measures | ||
| NCT01598194 | Comparison of a Novel 22-gauge Core Biopsy Needle | ||
| NCT01311856 | Telephone Counseling-Mailed Materials Versus Internet Interventions in Overweight Cancer Survivors | ||
| NCT00452439 | A Study of Actonel for the Prevention of Bone Loss | ||
| NCT02724956 | Ambu AuraGain and Teleflex LMA Protector Fiberoptic Assessments in Elective Patients | ||
| NCT01995669 | Lenalidomide and Obinutuzumab in Treating Patients With Relapsed Indolent Non-Hodgkin Lymphoma | ||
| NCT01504919 | Reducing Cancer Disparities Among Latinos in Texas | ||
| NCT02411656 | Pembrolizumab in Treating Patients With Stage IV Metastatic or Recurrent Inflammatory Breast Cancer or Triple-Negative Breast Cancer Who Have Achieved Clinical Response or Stable Disease to Prior Chemotherapy |
